Erectile dysfunction - an update of current practice and future strategies.

about

Erectile dysfunction - an update of current practice and future strategies.

Item

http://www.wikidata.org/entity/Q35741898

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Erectile dysfunction - an update of current practice and future strategies.

@ast

Erectile dysfunction - an update of current practice and future strategies.

@en

type

Item

label

Erectile dysfunction - an update of current practice and future strategies.

@ast

Erectile dysfunction - an update of current practice and future strategies.

@en

prefLabel

Erectile dysfunction - an update of current practice and future strategies.

@ast

Erectile dysfunction - an update of current practice and future strategies.

@en

P1476

Erectile dysfunction - an update of current practice and future strategies.

@en

P2093

Asif Muneer

http://www.w3.org/2001/XMLSchema#string

Jas Kalsi

http://www.w3.org/2001/XMLSchema#string

P2860

Y-27632, an inhibitor of Rho-kinase, antagonizes noradrenergic contractions in the rabbit and human penile corpus cavernosum

Cholinergic nerves in human corpus cavernosum and spongiosum contain nitric oxide synthase and heme oxygenase.

The effect of superoxide dismutase on nitric oxide-mediated and electrical field-stimulated diabetic rabbit cavernosal smooth muscle relaxation.

Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction.

The epidemiology and pathophysiology of erectile dysfunction.

Central neural regulation of penile erection.

Cyclic nucleotide phosphodiesterases: relating structure and function.

Pharmacology of penile erection.

Coated implants and "no touch" surgical technique decreases risk of infection in inflatable penile prosthesis implantation to 0.46%.

Tolerability and pharmacokinetics of avanafil, a phosphodiesterase type 5 inhibitor: a single- and multiple-dose, double-blind, randomized, placebo-controlled, dose-escalation study in healthy Korean male volunteers.

P304

210-219

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2051415813491862

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279066660

http://www.w3.org/2001/XMLSchema#string

P698

26097710

http://www.w3.org/2001/XMLSchema#string

P932

4467226

http://www.w3.org/2001/XMLSchema#string